Married to Medicine Los Angeles viewers watched the heartbreak Dr. Imani Walker endured when she decided to end her marriage.

Walker, who is a psychiatrist, confided in her mother, Paula Madison during the emotional episode. Madison not only comforted her daughter but she also delivered sage advice. A viewer wondered if Madison was also a psychiatrist or a psychologist. But Walker revealed, Shes neither. She was a journalist back in the day.

Indeed Madison was a journalist. In fact, she was once an executive with NBC who ended up launching her own powerful media company, Madison Media Management LLC. Like her daughter, Madison is a mighty force not only in media but also in music. Walker revealed that her mother had a friendship and professional relationship with iconic musician Prince.

Madison was an NBCUniversal executive for 35 years and then pivoted to create her own media company. She was named one of the 75 Most Powerful African Americans in Corporate America byBlack Enterprisemagazine in 2005 and in 2014. Madison is also an author and documentarian.

Walker revealed that her mother also owns The Africa Channel (TAC), which had a somewhat icy relationship with Comcast. Madison spoke out in December about the lack of cable programming diversity, especially with regard to Byron Allen versus Comcast.

RELATED: Bravos Married to Medicine LA Cast Express Frustration About the Treatment of Black Folks in America

Although Comcast has not shut out TAC, Comcast has not been a good business partner, she wrote in an open letter. With an unkept yet repeated promise by Comcast of 4 million additional subscribers its inaccurate to include TAC in any grouping of black-owned independent networks which would typify the Comcast business relationship as good or in any way proactive.

Walker revealed that she and her mother knew Prince. My mother met [Prince] through another friend of hers. My family used to own the LA Sparks, the womens basketball team, Walker said on the Behind the Velvet Rope with David Yontef podcast. And they also own this station called The Africa Channel. So my mother and Prince were trying to collaborate. Something with The Africa Channel to air.

Walker said her mother also appeared in a Prince video too. Do you remember the video where Kim Kardashian, Prince kicked her off the stage, Walker asked. And then somebody else came on afterward and was dancing? Thats my mom. So we were at that concert.

RELATED: Bravos Married to Medicine LA: Dr. Imani Walker Reveals How She Knew Prince

She also shared a sweet story about her encounter with Prince. I actually did go on stage later on in the show and he was like, Come dance with me. And I was way too scared, she said. But I did get to talk to him at the after party and we were talking about the Arab Spring and he was just so beautiful and his eyes were perfectly lined.

Walker revealed a fans dream come true too. He jumped up, and he had on his heels and he jumped up from the little booth we were sitting in, she shared. He jumped up and his leg touched my arm and I was like Im never washing this part of my arm again. And then he just got up and started playing this concert for hours and hours.

Continued here:

Bravo's 'Married to Medicine LA': Dr. Imani's Mother Is a Former Network Executive Who Knew Prince - Showbiz Cheat Sheet

The reaction to President Trumps endorsement of hydroxychloroquine (HCQ) provides a textbook example of how the media automatically pushes back against anything the president says or does.

The anti-Trump propaganda machine were apoplectic when Trump announced he was taking it himself, as prescribed by his doctor.

Approved for medical use in the United States in 1955, HCQ is on the World Health Organizations list of essential medicines, as one of the safest and most effective medicines needed in any health system. Its been prescribed hundreds of millions of times worldwide and has saved millions of lives as a malaria drug.

Nevertheless, celebrity medical experts knew better. Joy Behar of The View said anyone who takes hydroxychloroquine is crazy. Barbara Streisand speculated that Trump says hes now taking hydroxychloroquine . . . could it be because he has a small stake in the company that owns it? Bette Midler said the side effects are paranoia, hallucinations and psychosis.

Jimmy Kimmel chimed in with I thought about it for a long time last night, and Ive come to what I think is the only reasonable conclusion. Hes trying to kill himself.

(On a personal note, Ive been taking 400 milligrams of HCQ daily for more than five years for rheumatoid arthritis, with no side effects that Im aware of.)

A more serious example of how politics has contaminated rational debate was provided by Lancet. On May 15, this so-called unbiased medical journal ran an unsigned editorial saying American voters should replace Trump: America must put a president in the White House who should understand that public health should not be guided by partisan politics.

Lancet followed up with research saying that HCQ caused 30 percent increase risk of death for hospitalized COVID-19 patients. Some 120 doctors, epidemiologists and statisticians challenged the validity of the study, saying scrutiny has raised both methodological and date integrity concerns. Lancet admitted the study was flawed and disavowed it.

Lancet editor-in-chief Richard Horton told the Australian Guardian newspaper, This is a shocking example of research misconduct in the middle of a global health emergency.

Unfortunately, this isnt shocking to anyone who follows the knee-jerk hostility to Trump.

Jim Grodnik

Brevard

The rest is here:

The Media's Bad Medicine - The - The Transylvania Times

WASHINGTON - Note: Today, U.S. Reps. Jan Schakowsky (D-Ill.), Lloyd Doggett (D-Texas), Francis Rooney (R-Fla.), Rosa DeLauro (D-Conn.) and Peter Defazio (D-Ore.) introduced the Make Medications Affordable by Preventing Pandemic Pricegouging (MMAPPP) Act and the Taxpayer Research and Coronavirus Knowledge (TRACK) Act.

President Donald Trumps sycophancy to drug corporations is endangering the nations pandemic response. Although public investments are driving drug and vaccine development, the Trump administration is permitting drug companies to retain monopoly control over the drugs and vaccines, including those still under development. The administration is refusing to use its existing authorities to enable knowledge sharing and generic competition. Nor is the administration seeking enhanced powers from Congress. The certain result will be profiteering, rationing and inadequate supplies of the medicines and vaccines desperately needed to treat and eliminate the virus.

SCROLL TO CONTINUE WITH CONTENT

Theres no way around it. No ads. No billionaires. Just the people who believe in this mission and our work.

If you believe the survival of independent media is vital to do the kind of watchdog journalism that a healthy democracy requires, Please support non-profit Common Dreams today:

By contrast, the legislative proposals from Reps. Schakowsky and Doggett prioritize public health over Big Pharmas profits. Recognizing that leading candidate vaccines and drug treatments are built on public science and hundreds of millions in taxpayer dollars, their proposals would ensure, first, that the American people know how their money is being spent and what, if anything, our government is asking of the corporations that receive massive taxpayer grants. Additionally, their proposals would ensure that publicly funded treatments and vaccines for COVID-19 are reasonably priced, open to generic competition and available to the world, to prevent medical rationing that could scar a generation.

This is about way more than ensuring taxpayers arent ripped off, as important as that objective is. Promoting transparency and reasonable pricing of COVID-19 treatments and vaccines is a life-and-death matter. Public Citizen thanks Schakowsky and Doggett for their leadership and urges immediate passage of these bills.

###

Read the original post:

COVID-19 Medicine Pricing, Transparency Bills Are a Matter of Life and Death - Common Dreams

In our exclusive interview, Everett Vokes, MD, discusses the path that led him to specialize in head and neck cancer and lung cancer, personal and professional challenges he encountered along the way, and the ultimate importance of bringing multimodality therapy to the forefront of treatment.

Welcome to a very special edition of OncLive On Air! Im your host today, Caroline Seymour

OncLive On Air is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

Today, we had the pleasure of speaking with Everett Vokes, MD, John E. Ultmann Professor, physician-in-chief, and chair of the Department of Medicine at the University of Chicago Medicine. Dr. Vokes is an internationally renowned expert in head and neck cancer, having pioneered combination chemotherapy and radiation as a first-line treatment for patients.

Dr. Vokes is also the recipient of the new Translational Research Professorship from the American Society of Clinical Oncology, as well as the Francis L. Lederer Foundation grant for research on the malignancies of the upper aerodigestive tract.

In 2013, Dr. Vokes was recognized as the OncLive Giant of Cancer Care for Head and Neck Cancer for his tremendous achievements.

In our exclusive interview, Dr. Vokes discussed the path that led him to specialize in head and neck cancer and lung cancer, personal and professional challenges he encountered along the way, and the ultimate importance of bringing multimodality therapy to the forefront of treatment.

Read more:

Marvels in Medicine: Vokes's Venture to Bring Combined Modality Care to Patients With Cancer - OncLive

An online game that lets students learn about stem cells and tissue engineering also offered them information about high school and college internship programs to further spur their interest in regenerative medicine.

Through the game, aimed mainly at seventh graders through high school seniors, students competed in daily challenges to win swag and the chance to meet inventor Dean Kamen (virtually in this pandemic age).

The vision is to help inform young people about all the really cool things that are happening in this space, said Alexander Titus, the freshly minted chief strategy officer at the Advanced Regenerative Manufacturing Institute in Manchesters Millyard.

The game helps to inspire students as they choose their classes, their elective classes in high school and particularly majors in college, Titus said last week.

Nearly 100 students took part in the game, which ended Friday. The content about regenerative medicine will remain online through June.

ARMI, which is working to manufacture human tissue commercially, is working on recruiting tomorrows workforce one cool video at a time.

I think the timing of this couldnt be any better, said Julie Demers, executive director of the New Hampshire Tech Alliance. The pandemic has limited in-person, work-based learning opportunities and interactions with industry professionals. Interactive opportunities to get students interested in and thinking about career opportunities are critical.

Titus said a chief goal is to build a pipeline of future workers.

Its all tied together in attracting students while theyre young to understand the process of what to study along the way to get to college and a job when theyre done, said Titus, who earned a Ph.D. in quantitative biomedical sciences at Dartmouth.

Titus said he expects the game to help ARMI officials learn what draws the interest of students so they can develop other programming they know will garner student interest, he said.

The ARMI challenge, called TEMPtation, featured profiles of businesses from more than a dozen states as well as universities and colleges interested in regenerative medicine.

Arizona State University holds summer camps for middle and high school students that are interested in learning more about science and mathematics, read one profile.

From Georgia Tech in Atlanta: Georgia Tech has a Center for Career Discovery & Development, which offers internships, co-ops, and career services that give students the resources they need to support their search for employment following their graduation.

Formerly employed at the U.S. Department of Defense, Titus returned to New Hampshire to join ARMI.

The mission, he said, is marrying science and manufacturing.

Bring the science to the stage where we can automate it and market the new technologies we couldnt make before, said Titus, previously assistant director for biotechnology within the Office of the Under Secretary of Defense for Research & Engineering.

ARMI features more than 150 partners and more than $300 million in government and private investment committed.

If we want to be able to produce a replacement heart for people who have heart disease, what are the components that go into that? Titus said.

He hopes ARMI can attract startups in the Manchester area, allowing for ARMI to mentor them until they are viable companies.

The idea is for companies to move into New Hampshire and move into our ecosystem if you will, Titus said.

I think especially given now, where were seeing so many people in the cities during COVID have a hard time social distancing, I expect well see some shifting of people out of the cities, said Titus, who speculated some could settle in New Hampshire.

Whats Working, a series exploring solutions for New Hampshires workforce needs, is sponsored by the New Hampshire Solutions Journalism Lab at the Nackey S. Loeb School of Communications and is funded by Eversource, the New Hampshire Charitable Foundation, Dartmouth-Hitchcock Medical Center, the New Hampshire College & University Council, Northeast Delta Dental and the New Hampshire Coalition for Business and Education. Contact reporter Michael Cousineau at mcousineau@unionleader.com. To read stories in the series, visit unionleader.com/whatsworking.

Read the rest here:

Online game looks to stoke interest in regenerative medicine - The Union Leader

The Global Artificial Intelligence In Precision Medicine Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Artificial Intelligence In Precision Medicine Market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types, and end industries. This Artificial Intelligence In Precision Medicine Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

The global Artificial Intelligence In Precision Medicine market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025.

Top Companies: Intel AI, IBM, GE Healthcare, Thermo Fisher Scientific, Qiagen, Berg Health, Medasense Biometrics,

Get a sample copy Of this Report:

https://www.marketinsightsreports.com/reports/06172095179/covid-19-impact-on-global-artificial-intelligence-in-precision-medicine-market-size-status-and-forecast-2020-2026/inquiry?Mode=31

Overview: Artificial intelligence (AI) in medicine is used to analyze complex medical data by approximating human cognition with the help of algorithms and software. The development of novel pharmaceuticals and biologicals through clinical trials can take more than a decade and cost billions of dollars during that tenure period. AI technology can help to make this process faster and cheaper, which in turn is expected to help improve the efficiency of pharmaceutical and biotechnology companies.

Global Artificial Intelligence In Precision Medicine Market Split By Product Type And Applications:

This report segments the global Artificial Intelligence In Precision Medicine Market on the basis ofTypesare:

HardwareSoftwareServices

On the basis ofApplication, the Global Artificial Intelligence In Precision Medicine Market is segmented into:

OncologyNeurosciencesImmunologyRespiratoryOthers

Regional Analysis: For a comprehensive understanding of market dynamics, the global Artificial Intelligence In Precision Medicine Market is analyzed across key geographies namely: United States, China, Europe, Japan, Middle East & Africa, India, and others. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the market.

Explore Full Report With Detailed TOC Here:

https://www.marketinsightsreports.com/reports/06172095179/covid-19-impact-on-global-artificial-intelligence-in-precision-medicine-market-size-status-and-forecast-2020-2026?Mode=31

Influence of the Artificial Intelligence In Precision Medicine Market report:-Comprehensive assessment of all opportunities and risks in the Artificial Intelligence In Precision Medicine Market. Artificial Intelligence In Precision Medicine Market recent innovations and major events.-A detailed study of business strategies for the growth of the Artificial Intelligence In Precision Medicine Market-leading players.-Conclusive study about the growth plot of the Artificial Intelligence In Precision Medicine market for forthcoming years.-In-depth understanding of Artificial Intelligence In Precision Medicine Market -particular drivers, constraints, and major micro markets.-Favorable impression inside vital technological and market latest trends striking the Artificial Intelligence In Precision Medicine Market.

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Analytical Tools: The Global Artificial Intelligence In Precision Medicine Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porters five forces analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Finally, The Artificial Intelligence In Precision Medicine Market report is the believable source for gaining Market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and Market development rate and figure, and so on. This report additionally Present a new task SWOT examination, speculation attainability investigation, and venture return investigation.

We also offer customization on reports based on specific client requirement:

1-Freecountry level analysis forany 5 countriesof your choice.

2-FreeCompetitive analysis of any market players.

3-Free 40 analyst hoursto cover any other data points

About Us:MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

[emailprotected]|[emailprotected]

See the original post:

Artificial Intelligence In Precision Medicine Market To Witness the Highest Growth Globally in Coming Years 2020-2026 - Cole of Duty

Every Married to Medicine cast member is a millionaire but does the newest addition really have a net worth of $500 million? Maybe at least she compared herself to someone with that fortune.

Buffie Purselleis married to a physician but has created her own empire as a personal finance and tax expert. She shared on CNBC in 2017 she built her net worth through a number of businesses shes created. She admits to working up to 12 hours a day and only sleeps a total of 40 hours per week.

Known as Buffie the Tax Heiress Purselle said, Im going to quote Beyonce when she said that she thinks she might be the black Bill Gates. I think I just might be the black, curvy, fabulous Marcus Lemonis-in-the-making. Marcus Lemonis has a net worth of $500 million. Shes undoubtedly a resourceful and powerful entrepreneur. However, other resources put Purselles net worth closer to $1 million.

Toya Bush-Harris and Dr. Heavenly Kimes both have a reported net worth of $4 million each. Kimes runs a successful dental practice in Atlanta who specializes in cosmetic dentistry. She often shares success stories on Instagram and patient transformation photos. Replacing missing teeth can restore your smile to optimal health, function and appearance. Dental implants are a great option for restoring your smile because the implants are designed to look, function and feel just like your natural teeth, and with proper care, they can last a lifetime, she recently shared along with a video.

RELATED: This Is How Much the Stars of Married to Medicine Make in Real Life

Bush-Harris is married to a physician and is a published author. She released the childrens book, SleepyHead Please Go To Bed!Bush-Harris created a tremendous social media following using the hashtag, #MommyChronicles.

Also worth $4 million is Mariah Huq who is a Married to Medicine creator and producer. Huq is married to Dr. Aydin Huq and she often entertains at her lavish home on the series.

Married to Medicine top docs all have a net worth ranging from $3.5 to $3 million. Dr. Simone Whitmore has a net worth of $3.5 million as one of the most sought after OB/GYNs in the Atlanta area. Whitmore is a mother of two and has been with husband Cecil for 23 years. Viewers witnessed the couple experiencing rocky moments throughout the series.

Dr. Jacqueline Walters has a net worth of $3 million is also a highly respected OB/GYN in Atlanta. Walters is a published author and a two-time breast cancer survivor. She also openly discussed her infertility on the series.

RELATED: After Hesitating To Start a Family With Her Ex-Husband, Married To Medicine Star Quad Webb Has Adopted a Daughter

Also, with a net worth of $3 million is Dr. Contessa Metcalfe. Metcalfe focuses her practice on preventative medicine and became friends with Dr. Britten Cole while in the Navy. Metcalfe became the crossover cast member between Married to Medicine and Married to Medicine Los Angeles.

Quad Webb is a millionaire in her own right. With a reported net worth of $1.5 million, Webb was a medical sales representative when she first joined the series. But now owns Picture Perfect Pup, a specialty brand designed for dogs. She was originally married to Dr. Gregory Lunceford but the couple has since divorced. Webb recently adopted a baby.

Link:

Does a 'Married to Medicine' Cast Member Have a Net Worth of $500 Million? - Showbiz Cheat Sheet

CMI presents an in-depth overview of the Global Regenerative Medicine Market Study, detailing the latest product/industry coverage and market forecasts and status by 2027. Market research is categorized as a key area to accelerate marketization. The current market is evolving its presence and some of the major players in the study are Depuy Synthes, Inc., Orthofix, Inc., NuVasive, Inc. and Zimmer Holdings, Inc..

This study focuses on the Global Regenerative Medicine market status, future forecast, growth opportunity, key market, and emerging players. The study objectives are to present the Regenerative Medicine growth in Key regions. In order to provide valuable insight by each key element of the market, the highest and slowest growing market segment in the study is described. Newmarket participants are emerging and are accelerating the transition in the antistatic market. Merger and acquisition activities are expected to change the market environment for this industry.

You Keep Your Social Distance And We Provide You A Social DISCOUNT Use QUARANTINEDAYS Code In Precise Requirement And Get FLAT $1,000 OFF On All CMI Reports.

We Do Offer Sample of this report. Kindly go through the follow information in order to access sample copy.

Note- This report sample includes:

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (Structure Of The Report)

Research methodology adopted by Coherent Market Insights

Request A Sample Copy Regenerative Medicine Market Report Click here: https://www.coherentmarketinsights.com/insight/request-sample/163

The Global Regenerative Medicine is segmented by:

By Product Type: Global Regenerative Medicine Market, By Application.

Regional Markets: United States, Europe, China, Japan, Southeast Asia, India & Central & South America

List of Companies Mentioned: Depuy Synthes, Inc., Orthofix, Inc., NuVasive, Inc. and Zimmer Holdings, Inc.

1) Does Study provide Latest Impact on Market due to COVID & Slowdown?

Yes, the study has considered a chapter on Impact Analysis and this 2020 Edition of the report provides detailed analysis and its impact on growth trends and market sizing to better understand the current scenario.

2) How companies are selected or profiled in the report?

List of some players that are profiled in the report includes Depuy Synthes, Inc., Orthofix, Inc., NuVasive, Inc. and Zimmer Holdings, Inc.. the list is sorted to come up with a sample size of at least 50 to 100 companies having greater topline value to get their segment revenue for market estimation.

** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.

3) Is it possible to narrow down business segments by Application of this study?

Yes, depending upon the data availability and feasibility check by our Research Analyst, a further breakdown in business segments by end-use application in relation to type can be provided (If applicable) by Revenue Size or Volume*.

4) What is the base year of the study? What time frame is covered in the report?

Furthermore, the years considered for the study are as follows:

Historical year 2014-2019

Base year 2019

Forecast period** 2020 to 2027 [** unless otherwise stated]

Use QUARANTINEDAYS Code In Precise Requirement And Get FLAT $1,000 OFF On This Reports

Enquire here get customization & check discount, please click: https://www.coherentmarketinsights.com/insight/request-discount/163

** We will also include opportunities to utilize in micro markets that stakeholders can invest in, a detailed analysis of key competitors, and key services. **

Global Regenerative Medicine Market What to expect from this report:

Focused Study on Niche Strategy and Market Development & penetration Scenario

Analysis of M&As, Partnership & JVs in Global Regenerative Medicine Industry in the United States & Other Emerging Geographies

Top 10 Global Regenerative Medicine Companies in Global Market Share Analysis: Leaders and Laggards in 2017, 2019

Gain strategic insights on competitor information to formulate effective R&D moves

Identify emerging players and create effective counter-strategies to outpace competitive edge

Identify important and diverse product types/services offering carried by major players for market development

And many more .

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: Global Regenerative Medicine MARKET LANDSCAPE

Market EntropyMarket segmentation analysisMarket characteristics

PART 06: Global Regenerative Medicine MARKET SIZING

Market definitionMarket size and forecastMarket sizing

PART 07: Global Regenerative Medicine MARKET SEGMENTATION

SegmentationMarket opportunityComparison

PART 08: CUSTOMER LANDSCAPE

PART 10: DECISION FRAMEWORK

PART 09: REGIONAL LANDSCAPE

PART 11: MARKET DYNAMICS: DRIVERS, TRENDS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia.

**Be Safe and Stay Home**

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website http://www.coherentmarketinsights.com

Contact:

Coherent Market Insights1001 4th Ave, #3200 Seattle, WA 98154, U.S.Email: [emailprotected]United States of America: +1-206-701-6702United Kingdom: +44-020-8133-4027Japan: +050-5539-1737India: +91-848-285-0837

Follow this link:

Covid 19 Analysis On Regenerative Medicine Market: Comprehensive Study Explores Huge Growth of 2024 with Top Key Players Depuy Synthes, Inc.,...

Bioelectric Medicine Market Report Global analysis report is very helpful in understanding the Bioelectric Medicine market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better. The current market is evolving its presence and some of the major players in the study areGlaxoSmithKline, Medtronic Plc., Boston Scientific Corporation, Liva Nova Plc, Electrocore, Nevro, and St. Jude Medical..

The Bioelectric Medicine Market research study will give the answer to questions about the present performance of the market and the competitive scope, opportunity, challenges, cost, and more. The market can be divided based on product types and its sub-type, key applications, and major regions. Then it discusses recent product innovations and provides a scenario of potential regional market shares. It aims to fulfill your targeted customers understanding, needs, and wants as well as to explain how effectively a company can meet its requirements.

Note: *The Download PDF brochure only consists of Table of Content (ToC), Research Framework of the actual report, and Research Methodology adopted for it.

Request A PDF Sample Copy Bioelectric Medicine Market Report Click here: https://www.coherentmarketinsights.com/insight/request-pdf/1757

Highlights of the Global Bioelectric Medicine report:

Overall data will help improve clients competitive study, economic decision-making ability, as well as business planning, and the scope of futuristic developments in the global Bioelectric Medicine market. The complex data is explained in a well-structured manner by the experts and for which they used various analytical techniques and represent the data in the form of graphs, flowcharts, and diagrams.

Important Facts About Bioelectric Medicine Market Report:

The Bioelectric Medicine industry report features different approaches and procedures endorsed by the market key players to make vital business decisions.

The keyword market depicts some parameters such as production value, Bioelectric Medicine marketing strategy analysis, Distributors/Traders, and effect factors are also mentioned in this Bioelectric Medicine Market research report.

This research report reveals Bioelectric Medicine market overview, product overview, market share, supply chain analysis, demand and supply ratio, and import/export details.

Key Topics Covered in this Bioelectric Medicine Market Study:

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Market EcosystemMarket CharacteristicsMarket Segmentation Analysis

Part 05: Market Sizing

Bioelectric Medicine Market DefinitionMarket SizingMarket Size And Forecast

Part 06: Five Forces Analysis

Bargaining Power of BuyersBargaining Power of SuppliersThe threat of New EntrantsThreat of SubstitutesThreat of RivalryMarket Condition

Part 07: Customer Landscape Part 08: Regional Landscape

Geographical SegmentationRegional ComparisonAmericas Market Size And ForecastEMEA Market Size And ForecastAPAC Market Size And Forecast

Part 09: Decision Framework Part 10: Drivers And Challenges

Market DriversMarket Challenges

Part 11: Market Trends Part 12: Vendor Landscape

OverviewLandscape DisruptionVendors CoveredVendor ClassificationMarket Positioning Of Vendors

Have Any Query? Ask Our Industry Expert @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1757

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website http://www.coherentmarketinsights.com

Contact:

Coherent Market Insights1001 4th Ave, #3200 Seattle, WA 98154, U.S.Email: [emailprotected]United States of America: +1-206-701-6702United Kingdom: +44-020-8133-4027Japan: +050-5539-1737India: +91-848-285-0837

See the article here:

Covid-19 Impact On Bioelectric Medicine Market Report-Impact Of The Virus On Leading Companies In The World. GlaxoSmithKline, Medtronic Plc., Boston...

TRUMBULL, Conn., June 16, 2020 /PRNewswire/ --ZetrOZ Systems, maker of wearable ultrasound device sam, is encouraged by a double-blind RCT study published recently in the Journal of Pain Researchby the Orthopaedic Foundation, Stamford, Connecticut,found that low-intensity continuous ultrasound treatment significantly reduced upper trapezius myofascial pain of the neck and shoulder. Results indicated that applying daily continuous ultrasound treatment of 18,720 joules delivered by a wearable sustained acoustic medicine (sam) device caused a clinically meaningful improvement in the global rate of change (GROC) scores for patients.

Low-intensity continuous ultrasound is an emerging high-dosimetry low-intensity continuous ultrasound-based therapy that facilitates accelerated tissue healing and treats myofascial pain. In this instance, low-intensity continuous ultrasound treatment was evaluated for chronic upper neck and shoulder pain in a randomized, multi-site, double-blind, placebo-controlled study.

The level 1 study followed the nationally recognized Consolidated Standards of Reporting Trials (CONSORT) guidelines that were used to recruit and conduct the clinical efficacy trial. Thirty-three patients with upper trapezius myofascial pain were randomized for treatment with active (n=25) or placebo (n=8) devices. Investigators and subjects were blinded to treatment groups. Patients self-reported their pain level daily, rating it from zero to 10 on the numeric rating scale (NRS).

If pain rating was more significant than or equal to three, the sam device (3MHz,0.132W/cm2,1.3W, four hours) was self-applied for total energy dosimetry of 18,720 joules per treatment. During the four-week study, the daily pain rating was recorded. If sam-treatment was delivered, pain before, during and after treatment was recorded along with the global rate of change (GROC). Statistical analysis was used to assess changes from the baseline and differences between treatment groups.

Patients treated with active sam treatment observed a significant mean pain reduction of 2.61-points for active (p<0.001), compared to 1.58-points decrease from baseline for placebo (p=0.087) - resulting in a 1.03-point significant decrease in the active group over placebo (p=0.003). The overall GROC was significantly higher in the active group at 2.84 points compared to the placebo group at 0.46 points (p<0.001).

"We are greatly encouraged by the results of this double-blind RCT study. The clinical outcome confirms the value to patients, providers and payers who use sam to relieve pain and reduce medication, including upper trapezius myofascial pain of the neck and shoulder. sam does not just reduce pain, but the device also has the ability to treat arthritis and soft tissue injuries," said Dr. George Lewis, chief executive officer of ZetrOZ Systems.

Reference to Study

Petterson S,1Plancher K,1-4Klyve D,5 Draper D,6 Ortiz R.7 Low-Intensity Continuous Ultrasound for the Symptomatic Treatment of Upper Shoulder and Neck Pain: A Randomized, Double-Blind Placebo-Controlled Clinical Trial. J Pain Res. 2020;13:1277-1287

https://doi.org/10.2147/JPR.S247463

1Orthopaedic Foundation, Stamford, CT, USA; 2Department of Orthopaedics, Albert Einstein College of Medicine, New York, NY, USA; 3Department of Orthopaedics, Weill Cornell Medical College, New York, NY, USA; 4Plancher Orthopaedics & Sports Medicine, New York, NY 10128, USA; 5Department of Mathematics, Central Washington University, Ellensburg, WI, USA; 6Department of Exercise Sciences, Brigham Young University, Provo, UT, USA; 7Medical Pain Consultants, Dryden, NY, USA

About ZetrOZ Systems

ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produced UltrOZ, samSport and samPro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.comand samrecover.com.

Related Images

image1.jpg

SOURCE ZetrOZ Systems

Home

The rest is here:

New Research Finds that Sustained Acoustic Medicine (sam) Treatment Significantly Reduced Pain of the Neck and Shoulder - PRNewswire

A cheap, readily available steroid drug reduced deaths by a third in patients hospitalized with Covid-19 in a large study, the first time a therapy has been shown to possibly improve the odds of survival with the condition in the sickest patients.

Full data from the study have not been published or subjected to scientific scrutiny. But outside experts on Tuesday immediately embraced the top-line results. The drug, dexamethasone, is widely available and is used to treat conditions including rheumatoid arthritis, asthma, and some cancers.

In a statement, Patrick Vallance, the U.K. governments chief scientific adviser, called the result tremendous news and a ground-breaking development in our fight against the disease. Scott Gottlieb, a former commissioner of the U.S. Food and Drug Administration, called it a very positive finding in an interview on CNBC. I think it needs to be validated, but it certainly suggests that this could be beneficial in this setting.

advertisement

Atul Gawande, the surgeon, writer and public health researcher, urged caution, tweeting, after all the retractions and walk backs, it is unacceptable to tout study results by press release without releasing the paper.

The study randomly assigned 2,104 patients to receive six milligrams of dexamethasone once a day, by mouth or intravenous injection. These were compared to 4,321 patients assigned to receive usual care alone.

advertisement

In patients who needed to be on a ventilator, dexamethasone reduced the death rate by 35%, meaning that doctors would prevent one death by treating eight ventilated patients. In those who needed oxygen but were not ventilated, the death rate was reduced 20%, meaning doctors would need to treat 25 patients to save one life. Both results were statistically significant.

There was no benefit in patients who didnt require any oxygen. The researchers running the study, called RECOVERY, decided to stop enrolling patients on dexamethasone on June 8 because they believed they had enough data to get a clear result.

Dexamethasone is the first drug to be shown to improve survival in COVID-19, Peter Horby, one of the lead investigators of the study and a professor in the Nuffield Department of Medicine at the University of Oxford, said in a statement. He added that the drug should now become the standard treatment for patients with Covid-19 who need oxygen. Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.

A different arm of the same study showed on June 5 that hydroxychloroquine, widely touted as a potential Covid treatment, had no benefit in hospitalized patients. Yesterday, based in part on those results, the Food and Drug Administration revoked an Emergency Use Authorization for using hydroxychloroquine in those patients.

From the start of the pandemic in March, researchers have focused on two different stages of Covid-19, which will likely require very different interventions. Some drugs are designed to directly combat the novel coronavirus, SARS-CoV-2, that causes the disease. The first medicine shown to have a benefit, remdesivir from the biotech firm Gilead Sciences, falls into this category, even though, because it must be given intravenously, it has been tested in hospitalized patients. Remdesivir shortens the course of infection, but has not been shown to save lives.

After patients have become profoundly sick, the problem starts to become not only the virus but their own immune system, which attacks the lungs, a condition called acute respiratory distress syndrome, or ARDS. For these patients, doctors have believed, they would need to dampen patients immune response even as they fought the virus.

Initially, excitement in this area fell on new and expensive drugs, such as Actemra, a rheumatoid arthritis drug from Roche that is used to treat a similar condition caused by some cancer immunotherapies. But a study in patients who needed oxygen showed no benefit from a similar drug, although another arm in sicker patients is continuing. The National Institutes of Health is conducting a study of an Eli Lilly pill targeting rheumatoid arthritis, an extension of the study that showed remdesivir has a benefit.

Dexamethasone, which reached the market 59 years ago, seemed an unlikely candidate to help these patients; it was seen as too crude a way of tamping down the immune system. In guidelines for physicians treating the disease, the NIH doesnt even mention the therapy.

Studies that are testing other medicines may now need to incorporate the use of the drug, which could complicate analyzing the results. A spokesperson for Regeneron, which is testing Covid-19 drugs focused on both attacking the virus and dampening the immune system, said the companys studies are written so that when a new medicine becomes the standard of care, it becomes available to patients in the trial.Some studies have shown a benefit for using dexamethasone in acute respiratory distress syndrome not related to Covid-19, although the benefit was smaller than in RECOVERY.

The result, should it hold up to further scrutiny, shows the benefit of the strategy of Horby and Martin Landray, the Oxford researchers who designed the study, leveraging the U.K. health system to start a study of multiple inexpensive potential Covid-19 therapies including hydroxychloroquine, dexamethasone, and also some older HIV medicines. Several months into the Covid-19 pandemic, two of the most important results come from this single study.

Neither of those results, however, have been scrutinized or published.

More here:

Major study finds steroid reduces deaths in patients with severe Covid-19 - STAT

Boston-based Akili Interactive Labs has secured the first-ever FDA approval to marketa prescription video game and, in the process, created a new class of treatment delivered in pixels instead of pills.

Federal regulators on Monday cleared Akili's debut game, "EndeavorRx," to treat ADHD in children between 8 and 12 years old. The game features racing scenes that may recall Mario Kart, for some parents, butEndeavorRx isn't all fun.

"No question it is a good experience, but it's designed to be very difficult and repetitive it has to be, to have the effect we need on the brain," said Akili Chief Executive Eddie Martucci. "We set expectations: There will be ebbs and flows, in terms of frustration or children being able to engage in it. It gets pretty tough."

The goal is to stimulate brain activity that gradually strengthens a child's attention and focus.Martucci said a typical, initial prescription will call for 30 minutes of gameplay, five days per week, for one month. Parents and doctors can then reassess and consider renewal.

In a series of clinical trials, Akili reported that roughly half of children showed improved attention after a month, according to their parents. About two-thirds made gains after two months.

Akili aims to make EndeavorRx available for download on Apple devices within a few months, said Martucci, who declined to disclose the game's price. He said it is unlikely that insurers will cover EndeavorRx, at first, "but we're very committed to working with the insurance industry and making sure that patients can get this covered."

That insurance coverage may be possible is a testament to the increasing acceptance of video games in mainstream culture. In the 1990s, video games were the scornful subjects of congressional hearings and were widely blamed for contributing to the Columbine school shooting.

Public attitudes about video games haven't completely reversed since then. Just last year,President Trump suggested a link between violent games and several mass shootings. But a body of research casts doubt on the existence of such a connection, and video games have gained a legitimacy that might once have seemed unthinkable.

Top gamers canearn millions in professional tournaments. Universities offer advanced degrees in game design. Now, the FDA says a video game can treat a medical condition.

"This FDA approval is a major milestone in the work of games and the recognition of it," said Casper Harteveld, who chairs Northeastern University's graduate program in game science and design. "I hope to see more of it."

Other video game makers could follow Akili, which spent nine years developing EndeavorRx and raised more than $140 million of venture capital, according to Crunchbase. The FDA has created a new regulatory classification for "digital therapies," making it easier for future games to earn the agency's approval.

Jeffrey Shuren, who directs the FDA's Center for Devices and Radiological Health, called Akili's game "an important example of the growing field of digital therapy and digital therapeutics." He added that "the FDA is committed to providing regulatory pathways that enable patients timely access to safe and effective innovative digital therapeutics."

Go here to read the rest:

This Won't Hurt A Bit: A New Prescription Medicine Is ... A Video Game - WBUR

Photo Submitted

The University of Arkansas is one of only 166 universities and colleges around the world to be honored by the American College of Sports MedicineExercise is Medicineinitiative for its efforts to create a culture of wellness on campus.

Erin Howie Hickey, assistant professor of exercise science in the College of Education and Health Professions, is the advisor for the Exercise is Medicine Registered Student Organization at the U of A. The RSO, which is only two years old, earned a silver level designation from the Exercise is Medicine On Campus program.

Bryce Daniels, Hickey's graduate assistant who is also passionate about promoting physical activity, helped rally students to join the RSO.

"We were lucky to gain the support from driven exercise science undergrad students, the Health, Human Performance, University Recreation, the College of Education and Health Professions, and the Pat Walker Health Center to really start the Exercise is Medicine initiative at the University of Arkansas," Daniels said.

In the first year, the RSO developed a campus event called Exercise is Medicine Field day, which has been held every semester since then. In addition to Daniels, other students from the HHPR department who have led the charge on the U of A campus are Sally Barnes, Sarah Schwartz, Sarah Jenkins, Nathan Garcia, Kayla Accurso and Kylar Eagle.

"We partner with University Recreation to check out a variety of lawn games and have a college recess for students to enjoy between classes and promote physical activity," he said.

In the fall of 2020, students in the organization wanted to continue to grow the initiative across campus, so they created a websiteto keep the public and U of A community in the loop about events and the Exercise is Medicine research study.

"The research study investigates various health behaviors and health statuses of students, faculty, and staff at our university," Daniels said. "The website also links to our social media pages where informative videos of how to properly perform a variety of exercises and post work recovery techniques can be found."

Daniels said the organization will continue to work with Pat Walker Health Center to inquire about physical activity at each appointment, just like the would measure heart rate and blood pressure. The RSO would also like to grow the initiative by seeking student involvement from different departments across campus.

Students also envision spreading the initiative into the Northwest Arkansas community, he said.

Hickey is proud of the impact her students are making through Exercise is Medicine.

"They are gaining momentum, as shown by the silver recognition," she said. "They have been growing partnerships towards a long term goal of making our campus an example of how exercise truly is medicine."

Universities and colleges that earned gold, silver and bronze status were officially recognized in a virtual ceremony on Friday (June 12).

The national Exercise is Medicine On Campus launched its recognition program in 2014 to honor campuses that encourage faculty, staff and students to work together to improve the health and well-being of the community.

Original post:

U of A Recognized by Exercise is Medicine for Efforts to Create Culture of Wellness on Campus - University of Arkansas Newswire

Robert L. Coleman, MD, FACOG, FACS, chief scientific officer of The US Oncology Network, discusses the utility of biomarkers in precision medicine.

The discovery of new elements in tumor biology is an exciting space, however, only certain elements can be labeled as predictive, explains Coleman. In other words, while the element may be associated with the prognosis of the disease, using a drug that targets this factor may not lead to any benefits in a patients treatment. To date, such cases have not been common, although they are certainly beginning to emerge, says Coleman.

PARP inhibitors have always demonstrated great success, thus, they are a perfect example of the utility of biomarkers in precision medicine, adds Coleman. PARP inhibitors allow investigators to measure homologous recombination deficiency (HRD) in several ways. First, they help them fully understand different types of alterations, such as germline mutations and somatic mutations.

Additionally, PARP inhibitors help investigators identify a reflection of having global HRD in the tumor, which may not be associated with one specific tumor, explains Coleman. All in all, this is a very simple way to analyze predictive biomarkers and their impact on precision medicine.

Originally posted here:

Dr. Coleman on the Utility of Biomarkers for Precision Medicine in Ovarian Cancer - OncLive

This animal, the heavily trafficked pangolin, may be the key in how the new coronavirus spread from animals to humans. USA TODAY

China has officially removed pangolin scales from its 2020 list of approved ingredients used in traditional Chinese medicine, multiple media outlets report.

According to the countrys state-run media, the latest version of Chinese Pharmacopoeia for 2020 no longer includes the pangolin, which most scientists say may have transmitted the coronavirus from bats to humans as an intermediary animal.

Pangolins are small mammals covered in scales that live in Asia and Africa. Its scales are sometimes used as an ingredient in traditional Chinese medicine as a way to boost fertility, according to associate professor of East Asian politics at the University of Houston-Downtown Peter Li, and its meat is also considered a delicacy by some.

The armadillo-like animal is protected under international law, but theyre still widely trafficked as one of the most illegally traded mammals on the planet, says the Environmental Investigations Agency, with an estimated 1 million sold in the past 15 years.

Just last year in Zhejiang, authorities arrested 18 smugglers and confiscated 23.1 tons of pangolin scales sourced from an estimated 50,000 creatures, according to Chinese state media.

Zhou Jinfeng, secretary-general of the China Biodiversity Conservation and Green Development Fund, said China's native pangolins have been all but wiped out. Over the past five years, Zhou and volunteers found only five where hundreds of thousands lived just three decades ago.

Recent conservation efforts have worked to protect the eight pangolin species found in Asia and Africa threatened by illegal international trade. Earlier this month, China ordered its highest level of protection also forbidding the raising of pangolins in captivity.

'A loaded gun': Wet markets, wildlife trafficking pose threat for the next pandemic

What to know: Pangolins may have spread coronavirus to humans

The June 5 order from the National Forestry and Grassland Administration did not explicitly mention the outbreak as a reason for the measure, but the timing appears to indicate it could be part of Chinas nationwide crackdown on the wildlife trade following the pandemic.

Trade in wildlife including bats and pangolins has been linked to so-called zoonotic diseases that leap from animals to humans.

Zhou said the new protections give groups like his the right to sue businesses and individuals selling pangolin scales. However, he wants to go a step further by releasing into the wild all captive pangolins in China and burning all confiscated pangolin scales, similar to how Kenya incinerated seized elephant tusks in a bid to end the illegal trade that continues to this day.

Contributing: Deirdre Shesgreen, USA TODAY; Associated Press. Follow Adrianna Rodriguez on Twitter: @AdriannaUSAT.

Autoplay

Show Thumbnails

Show Captions

Read or Share this story: https://www.usatoday.com/story/news/health/2020/06/15/china-removes-pangolin-2020-list-traditional-medicines-coronavirus/3190016001/

Read more:

Pangolin, animal linked to coronavirus, removed from China's list of traditional medicines - USA TODAY

Visit the News Hub

Research may lead to treatment advances for patients with immobilizing illness, injury

Pictured is a high-fidelity map of physician-scientist Nico Dosenbachs brain while his dominant arm was in a cast for two weeks. The red and yellow areas of the MRI image represent previously undetected brain pulses. Dosenbach and colleagues at Washington University School of Medicine in St. Louis found that disuse of an arm causes the affected brain region to disconnect from the rest of the brains motor system within two days. However, spontaneous pulses maintain activity in the disused circuits until the region becomes active again when mobility is regained.

A neuroscientists neon pink arm cast led him and fellow researchers at Washington University School of Medicine in St. Louis to discover previously undetected neuronal pulses in the human brain that activate after an immobilizing illness or injury.

The pulses appeared on MRI scans used to measure brain activity of the neuroscientist and, later, two additional adults whose arms were in casts. The researchers compared those MRI images with scans of the scientists before and after their arms were put in casts.

The scans showed that the brains main circuits responsible for movement in specific areas of the body disconnected within 48 hours of a person wearing a cast that encumbered movement in such an area. Also during this time, disuse pulses emerged to maintain neural activity and allow the main motor circuits to reactivate if and when mobility was restored through physical therapy.

The findings, published online June 16 in Neuron, offer clues to how the brains billions of neurons cells that transmit nerve impulses can rewire and restore pathways after injury or illness. Understanding just what is behind this resiliency may lead to new therapies for people with broken limbs or recovering from strokes or other immobilizing conditions.

Many scenarios exist in neurology in which a person doesnt use an arm or a leg and, consequently, related brain circuits for an extended period of time, said senior author Nico Dosenbach, MD, PhD, an assistant professor of neurology. In offering the best care to patients, its important to understand specifically what changes occur in brain function. Accurate understanding and mapping of these circuits may lead to advancements in treating patients who have lost use of their limbs.

In 2015, Dosenbach also an assistant professor of occupational therapy, of pediatrics, of radiology and of biomedical engineering wore the pink cast for two weeks despite the fact he had no injury requiring one. He aimed to collect high-quality data using brain-imaging techniques to evaluate neural networks that control movement.

Many of the patients Dosenbach treats at St. Louis Childrens Hospital suffer from conditions that limit mobility and cause them to favor one side of the body. A common treatment is constraint-induced movement therapy, also known as forced-use therapy, which immobilizes the dominant arm with a cast, forcing the child to use the impaired arm.

My goal was a better understanding of what my patients experience during therapy, although I acknowledge its more difficult for them because of their disabilities, Dosenbach said.

He also wanted to pinpoint a timeline of when individual neural changes occur. Commonly, scientists gather MRI data from dozens of people and average it. But I did not want to do that because everyones brain is anatomically different, and when MRI data are averaged, it all blurs together, Dosenbach said.

So Dosenbach decided to wear a fiberglass cast on his dominant, right arm. It stretched from his fingertips to just below his shoulder. It was pink, the favorite color of his daughter, Maike, then age 2.

He wore it during the hot, humid summer. It itched. It was awkward. He had to learn how to change a diaper with one hand.

To study brain activity, Nico Dosenbach, MD, PhD, an assistant professor of neurology at Washington University School of Medicine in St. Louis, wore a fiberglass cast for two weeks.

Every day, he arose predawn to lie stiffly for 30 minutes for a resting-state functional MRI. He did this for the two weeks his arm was in the cast, as well as for the two weeks before and after.

During the six weeks, Dosenbach also wore accelerometers on both wrists to track the motor strength of his arms while performing basic tasks such as writing and moving objects.

It wasnt terrible, just unpleasant, Dosenbach recalled. But immediately, I noticed my right arm got worse, and my left hand got stronger. It was much faster than any of us expected.

The MRI data showed that brain changes occurred within 48 hours. Additionally, the researchers measured a decrease in grip strength in his right arm from 124 pounds of force to 90 during the two weeks he wore the cast.

Once my cast was removed, my right hand began to grow stronger, Dosenbach said. My left returned to its former role, too.

Surprised by such resiliency, Dosenbach and the studys first author, Dillan Newbold, a MD, PhD student, conducted the same experiment on two crazy-in-a-good-way scientists one who wore a fluorescent yellow cast decorated in doodles, the other a forest green cast that recalled childhood memories of camping.

Using a resting-state functional MRI scan, the researchers identified and measured the precise regions in each individuals brain that controlled each casted arm, examining more than 20 hours of recordings for each person. These techniques allowed the researchers to discover and characterize the pulses.

Their MRI data nearly mirrored Dosenbachs. The findings indicated that disuse of each arm caused affected neurons to disconnect from the rest of the brains motor system within two days. Newbolds analysis revealed that throughout the time the casts were worn, spontaneous pulses maintained activity in the disused circuits until the neurons began firing again when mobility was regained.

Finding the spontaneous pulses was incredible, Newbold said. People can be motionless, but their neurons seem to protect the brain from completely disengaging when its not being used. More research is needed, but this was the most exciting part of the study because of the clinical implications.

Newbold DJ, Laumann TO, Hoyt CR, Hampton JM, Montez DF, Raut RV, Ortega M, Mitra A, Nielsen AN, Miller DB, Adeyemo B, Nguyen AL, Scheidter KM, Tanenbaum AB, Van AN, Marek S, Schlaggar BL, Carter AR, Greene DJ, Gordon EM, Raichle ME, Petersen SE, Snyder AZ, Dosenbach NUF. Plasticity and Spontaneous Activity Pulses in Disused Human Brain Circuits. Neuron. Published online June 16, 2020. https://doi.org/10.1016/j.neuron.2020.05.007

This work was supported by the National Institutes of Health (NIH), grant numbers F31NS110332, NS088590, TR000448, MH1000872, 1R25MH112473, 5T32 MH100019-02, MH104592, NS080675, and 1P30NS098577 (to the Neuroimaging Informatics and Analysis Center); U.S. Department of Veterans Affairs Clinical Sciences Research and Development Service, grant 1IK2CX001680; Kiwanis Neuroscience Research Foundation; Jacobs Foundation, grant 2016121703; Child Neurology Foundation; McDonnell Center for Systems Neuroscience; Mallinckrodt Institute of Radiology, grant 14-011; Hope Center for Neurological Disorders.

Washington University School of Medicines 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.

Read the original post:

Previously undetected brain pulses may help circuits survive disuse, injury - Washington University School of Medicine in St. Louis

Virtual Reality in Medicine and Healthcare Market 2020

This report studies the Virtual Reality in Medicine and Healthcare Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Virtual Reality in Medicine and Healthcare Market analysis segmented by companies, region, type and applications in the report.

The major players covered in Virtual Reality in Medicine and Healthcare Market Google, Orca Health, Brain Power, Medsights Tech, AccuVein, Microsoft, EchoPixel, Augmedix, Atheer, Aira

The final report will add the analysis of the Impact of Covid-19 in this report Virtual Reality in Medicine and Healthcare industry.

Get a Free Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-virtual-reality-in-medicine-and-healthcare-market-size-status-and-forecast-2019-2025?utm_source=3wnews&utm_medium=36

Virtual Reality in Medicine and Healthcare Market continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. Virtual Reality in Medicine and Healthcare Market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Research objectives:

To study and analyze the global Virtual Reality in Medicine and Healthcare market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of Virtual Reality in Medicine and Healthcare market by identifying its various sub segments.

Focuses on the key global Virtual Reality in Medicine and Healthcare players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Virtual Reality in Medicine and Healthcare with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Virtual Reality in Medicine and Healthcare submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The Virtual Reality in Medicine and Healthcare Market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Table of Contents: Virtual Reality in Medicine and Healthcare Market

Chapter 1: Overview of Virtual Reality in Medicine and Healthcare Market

Chapter 2: Global Market Status and Forecast by Regions

Chapter 3: Global Market Status and Forecast by Types

Chapter 4: Global Market Status and Forecast by Downstream Industry

Chapter 5: Market Driving Factor Analysis

Chapter 6: Market Competition Status by Major Manufacturers

Chapter 7: Major Manufacturers Introduction and Market Data

Chapter 8: Upstream and Downstream Market Analysis

Chapter 9: Cost and Gross Margin Analysis

Chapter 10: Marketing Status Analysis

Chapter 11: Market Report Conclusion

Chapter 12: Research Methodology and Reference

Key questions answered in this report

What will the market size be in 2026 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Inquire More about This https://www.reportsandmarkets.com/enquiry/global-virtual-reality-in-medicine-and-healthcare-market-size-status-and-forecast-2019-2025?utm_source=3wnews&utm_medium=36

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

See more here:

Impact of COVID-19 Outbreak on Virtual Reality in Medicine and Healthcare Market to Witness Google, Orca Health, Brain Power, Medsights Tech, AccuVein...

By Sally Sehn on June 16, 2020.

The historic Hartley Block, located at 505 North Railway Street, is a brick two-storey building which pre-dates both the nearby Corona and Cecil Hotels. It was the first sizeable business building constructed on the north side of the Canadian Pacific Railway (CPR) tracks.

The Hartley Block was built in 1910 for Charles Henry Hartley, a CPR engineer who came to Medicine Hat in 1896. The building was designed by architect W.T. Williams and constructed by contractor M.C. Sackrider, at an estimated cost of $10,000. It contained fifteen suites on the upper level and two retail outlets on the lower level. Built before electricity was prevalent, gas lighting was installed for interior fixtures. The building boasted metallic (tin) ceilings, used extensively in the large departmental stores of the East.

In the fall of 1910, Mrs. Grace Chatterton leased the second storey as a boarding house, named Hartley Flats. It was a welcome addition during a time when the city was experiencing an economic boom and housing was considered inadequate. The A. J. Robinson dry goods store moved into the lower north outlet and H. Morrow, grocer, opened a business in the adjacent south outlet.

The most prominent retail business that operated out of Hartley Block was the C.P.R. Mens Store. In this location from 1912-1921, the business was owned and operated by Harold S. Ireland. After outgrowing the stores first North Railway Street location, Ireland relocated to the Hartley Block. He initially leased only the north side of the lower level. By 1918, the successful business had taken over the entire lower level. According to the Esplanade Archives, it is reported that during World War I, Ireland equipped the battalion from Medicine Hat with machine guns. The C.P.R. Mens Store actually, had no connection to the CPR. Ireland had obtained permission to use the CPR name from Supt. J.G. Cameron, then CPR Yard Master. By 1921, the prosperous business outgrew even the Hartley Block and moved to the substantial Lowe Block directly across from the CPR station. The C.P.R. Mens Store was in operation at this third and final location until 1963.

In 1914, Charles Hartley, on one of his out-of-town CPR runs, contracted typhoid fever, and died within three weeks. He was only 42. His wife Catherine took over the operation of the boarding house and the management of the retail leases.

Although most of the buildings historic red pressed brick exterior has been stuccoed over, the upper corbelled brickwork is intact. The Hartley Block, now occupied by the Mainliner Pub, is an integral part of the North Railway Street neighbourhood.

Sally Sehn is a Member of the Heritage Resources Committee of the City of Medicine Hat

You must be logged in to post a comment.

Read more:

Heritage in the Hat: The heart of North Railway - Medicine Hat News

By Maj Gen (Dr) VK Sinha

No drug has come more in the lay press in recent times than Hydroxychloroquine. It is in the news not because of its miraculous property, but because of the amount of controversy it has generated. The conflicting reports about this drug are an alternation between hope and despair in our fight against COVID19.

HCQ is a cheap generic drug that has been there for ages with its primary use in arthritis as an anti-inflammatory agent, but without credible evidence for use against viruses. India accounts for 70 percent of the global output, producing 10 times its domestic requirement. Notwithstanding the divided expert opinion on effectiveness, proving it beneficial has high stakes in business.

Higher are the stakes for Remdesivir, a new-on-the-block prohibitively expensive, patent-protected antiviral agent. Though its credentials are yet to be proven beyond doubt, the medical community is desperately hoping the drug would work. It has the potential for a windfall profit for Gilead Life Sciences. Humble Hydroxychloroquine may be a stumbling block between the potential and the real windfall.

What is interesting in this war is the turf itself. COVID-19, with all the panic notwithstanding, is but a mild disease with 90 percent of those tested positive not developing even a minor illness and only a tiny fraction actually needing any treatment. In an infection of this type, anything and everything can be proven to be effective unless subjected to intense scrutiny.

Leave aside torturing the data (a la Ronald Coase), even a small statistical jugglery can make a huge difference in such a setting. Some years ago Kotak Mahindra Bank ran a campaign 50% more interest on your savings account. It was actually a 6% vs 4% campaign. A 2% more can be shown as 50% more.

Bring this analogy to medical research. There are two groups of 200 patients each A on no drug (control) and B on drug (study). In the end, there are two adverse events in the control group and only one in the study group. It is actually a half percent real risk reduction that can also be called 50 percent relative risk reduction. This is just an example of a very honest research rephrased into smart marketing. And it is par for the course.

What is not, is deceit to discredit. This is precisely what happened to Hydroxychloroquine. On May 22, WHO issued an advisory to stop all clinical trials of Hydroxychloroquine, citing concerns of adverse side effects. The concern for adverse effects emanated from a preprint report in The Lancet (a journal of formidable standing in the medical world with a high impact factor) based on data provided by a dubious Illinois firm called Surgisphere that has neither the expertise nor the experience in the field of medicine.

Exposure on the credentials of the firm left many, including WHO and The Lancet, red-faced. In less than a fortnight, on June 2, WHO had to hurriedly rescind its earlier order, to be followed by The Lancet retracting thearticle on June04. You dont need a rocket scientist to deduce the role of business forces working behind the scene.

The issue before the medical fraternity is bigger than the effectiveness of a particular drug. It is more about our quest for truth. It relates to our raison dtre. The doctor, being a fiduciary, is bound ethically to act in the others (read patients) best interests. When truth is being manufactured in pursuance of a hidden agenda, the best interest of the patient is a natural casualty.

In 2005, Prof John Ionandis (presently Prof of Epidemiology at Stanford) highlighted the problem in his paper Why Most Published Research Findings Are False. Besides data manipulation, he highlighted the motive flagrant conflict of interest, financial and intellectual in that order. Business interest is prime mover, researchers can act in complicit, and at times active, collaboration out of both need and greed. It is now cancerous.

Richard Horton, editor of The Lancet has lamented his frustration, The case against science is straightforward: much of the scientific literature, perhaps half, may simply be untrue. Afflicted by studies with small sample sizes, tiny effects, invalid exploratory analyses, and flagrant conflicts of interest, science has taken a turn towards darkness. He goes on to add, The bad news is that nobody is ready to take the first step to clean up the system.

New England Journal of Medicine, unable to find authors without conflict of financial interest to write the review articles had to change its policy. Marcia Angell, editor NEJM for two decades is on record, It is no longer possible to believe much of clinical research that is published.

The situation for an ordinary practitioner is like the bewildered reader of Le Carres espionage novels, wondering till the end, who is crossing whom. Be it experts of repute, scientific journals, text books, good Samaritan institutions like WHO, or watchdogs like FDA none of them can come out clean on this slur.

Thanks to coronavirus, the helplessness of my fraternity being denied the basic entitlement of knowing the truth, has come to the fore. It is certainly not amusing.

(Writer is (retired) Prof & Head of Orthopaedics, AFMC, Pune. Views are personal)

DISCLAIMER : Views expressed above are the author's own.

See the original post here:

The manufactured science of Medicine - Economic Times

Longer life-expectancy is a cumulative effect of a healthy lifestyle and favorable environmental conditions. A trend of continuously increasing life expectancy has been a witness since a decade, primarily because of advances in medical sciences and treatment of chronic life-threatening diseases, availability of clean water and environment and other factors. This trend is projected to further show even more exponential growth graph owing to the anti-aging medicines, stem cell therapeutics, genetic screening and interventions, and high-tech biomedicines. American Academy of Anti-Aging Medicine claimed that anti-aging medicines can add up to 10-20 years to the life expectancy of a human. Today, a combination of calorie-restricted diet, regular exercise, and anti-aging medicines are claimed to slow the process of senescence and aging. Various medicines used against the treatment of acute or chronic diseases can be considered as anti-aging medicines, however, to define anti-aging medicine market we have considered only the drugs that are directly prescribed and used for delaying the effects of aging.

Get Free Sample Copy With Impact Analysis Of COVID-19 Of Market Report @https://www.persistencemarketresearch.com/samples/26233

The constantly growing demand to look young in old individuals and to remain young and youthful in young people drive the anti-aging market. The influence of aesthetics from the fashion and television industry propel the demand to retain the features and energy of younger age in old people. Additionally, the increasing number of anti-aging medicine manufacturers in the decade contribute to higher availability of the anti-aging medicine resulting in expansion of the global anti-aging medicine market. However, skeptical approach to anti-aging medicine as being an external stimulator of cell-cycles is a restraint to the expansion of anti-aging medicine market.

The global Anti-aging medicine market is segmented on basis of product type, age group, distribution channel, and region:

The rising demand for beauty consciousness amongst people and the desire to stay young is the primary factor fueling the growth of anti-aging medicines in the market. The acclaimed benefits of the products and affordability along with regional presence compel the demand for anti-aging medicine in the global market. Hormonal replacement therapy segment in product type is expected to account maximum market share in the terms of revenue in the global anti-aging medicine market. However, antioxidant therapy segment in product type is expected to grow with the highest CAGR over the forecast years owing to the rising awareness about the plethora of benefits of antioxidants in anti-aging among the public. On the basis of the route of administration, the global anti-aging medicine market is segmented as oral, injectable and topical, out of which oral segment is expected to generate maximum revenue share over the forecast period. As per the distribution channel, the global anti-aging medicine market is segmented as hospital pharmacies, retail pharmacies, e-commerce, and drug stores. The e-commerce segment in the distribution channel is estimated to grow with the highest CAGR over the forecast time.

You Can Buy This PMR Healthcare Report From Here @https://www.persistencemarketresearch.com/checkout/26233

Regionally, the global anti-aging medicine market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America anti-aging medicine market is projected to account for the largest market share in the terms of revenue in the global anti-aging medicine market owing to the higher healthcare expenditure and presence of numerous manufacturers. Europe is expected to hold the second largest share in the global anti-aging medicine market during the forecast period because of the growing geriatric population and higher spending on healthcare products and supplements. MEA anti-aging medicine market is expected to witness sluggish growth over the forecast time owing to the limited presence of manufacturers and lower healthcare expenditure. Asia Pacific is projected to grow with the highest CAGR over the forecast years in the global anti-aging medicine market due to higher demand from end users and regional penetration of the key players in the region.

Some of the players operating in the global anti-aging medicine market are Pfizer, Evolution GmbH, Himalaya Global Holdings Ltd., Cipla Limited, Mylan Laboratories, Novartis, Merck Group, Vitabiotics, William Ransom & Son Holdings Plc, Uni-Vite Healthcare and Health Made Easy Limited amongst others.

Read the original here:

Anti-Aging Medicine Market to Benefit from Rapid Technological Advancements During the Forecast Period 2018 2026 - 3rd Watch News